Promoting shared decision making and informed choice for the early detection of prostate cancer: Development and evaluation of a GP education program

Cancer Forum

Volumn 30, Issue 1, 2006, Pages 38-42

  Metcalfe, Robyn ^a   Russell, Rebecca ^a   McAvoy, Brian ^b   Tse, Justin ^c   Sutherland, Georgina ^a   Hoey, Louisa ^a  

^a CANCER EPIDEMIOLOGY CENTRE   (Australia)

^b National Cancer Control Initiative   (Australia)

^c UNIVERSITY OF MELBOURNE   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

ARTICLE; AUSTRALIA; CANCER DIAGNOSIS; CANCER RISK; DECISION MAKING; GENERAL PRACTITIONER; HUMAN; MEDICAL EDUCATION; PROSTATE CANCER;

EID: 33645458641     PISSN: 0311306X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (19)

1. Australian Institute of health and Welfare. Cancer in Australia 2001. Canberra: Australian Institute of Health and Welfare, 2004.
2. Coldman AJ, Phillips N, and Pickies TA. Trends in prostate cancer incidence and mortality: An analysis of mortality change by screening intensity. CMJA. 2003; 168(1): 31-35.
3. Waxman J and Phandha H. Do we know what's best for prostate cancer? EJC 1996; 32(9): 1455-1456.
4. Baade PD, Coory MD, Aitken JF. International trends in prostate cancer mortality: the decrease is continuing and spreading. Cancer Causes Control 2004; 15: 237-241.
5. Bill-Axelson A, Holmberg L, Ruutu M, et al. Radical prostatectomy versus waiting in early prostate cancer. New Engl J Med 2005; 352(19): 1977-1984.
6. Johansson J, Andren O, Andersson S, et al. Natural risk and history of early, localized prostate cancer. JAMA 2004; 291: 2713-2719.
7. Talcott JA. What patients should be told before agreeing to a blood test that could change their lives. Urology 2003; 61(1): 7-9.
8. Wilkinson S and Chodak G. Informed consent for prostate-specific antigen screening. Urology 2003; 61(1): 2-4.
9. Australian Health Technology Advisory Committee. Prostate Cancer Screening. 1996, Canberra: AGPS.
10. Coley CM, Barry MJ, and Mulley AG. Clinical guidelines part III: Screening for prostate cancer. Ann Intern Med Online 1997; 126: 480-484.
11. Harris R and Lohr KN. Screening for prostate cancer: An update of the evidence for the U.S. Preventive Services Task Force. Ann Intern Med Online 2002; 137: 917-29.
12. Whitney SN, McGuire AL, McCullough LB. Atypology of shared decision making, informed consent, and simple consent. Ann Intern Med 2004; 140: 54-9.
13. O'Connor AM, Fiset V, DeGrasse C, et al. Decision aids for patients considering options affecting cancer outcomes: evidence of efficacy and policy implications. J. Natl. Cancer Inst Monogr 1999: 67-80.
14. O'Connor A. Using patient aids to promote evidence-based decision making. EBM 2001; 6: 100-102.
15. Woolf SH, Krist AH, Johnson RE, et al. Unwanted control: How patients in the primary care setting decide about screening for prostate cancer. Patient Educ Couns. 2005; 56: 116-124
16. Bird S. Discussing benefits and risks with patients PSA testing. Aust Fam Physician 2004; 33:(4): 266-267.
17. Dunn IB, Kirk D. Legal pitfalls in the diagnosis of prostate cancer. BJU International 2000; 86: 304-307.
18. Pinnock C. PSA testing in general practice: can we do more now? MJA 2004; 180: 379-381.
19. Steginga S, Pinnock C, Baade P, et al. An educational workshop on the early detection of prostate cancer: A before-after evaluation. Aust Fam Physician 2005; 34: 889-891.